## Filing Overview **Registrant**: Rocket Lab USA, Inc. **Type of Filing**: [[Filing Definitions#Form 424(b)(5)|Form 424(b)(5)]] **Filing Date**: 2025-03-11 **Partner**: [[Mynaric]] **Securities Registered**: - Up to **$500,000,000** in Common Stock **Stock Exchange Listing**: Nasdaq (Symbol: RKLB) **Last Reported Price (March 10, 2025)**: **$17.12** per share **Sales Agreement**: - The company has entered into an **At-the-Market (ATM) offering** agreement with: - BofA Securities, Inc. - Cantor Fitzgerald & Co. - Stifel, Nicolaus & Company, Incorporated - TD Securities (USA) LLC - Sales agents will be entitled to a **3.0% commission** per share sold. ## Notes - **Rocket Lab USA, Inc.** filed a **Form 424(b)(5) Prospectus Supplement** on **March 11, 2025**, enabling the company to **sell up to $500 million worth of common stock** via an **At-the-Market (ATM) offering**. - Proceeds from the stock sales will be used for **general corporate purposes, potential future acquisitions, and working capital**. - The company has entered into a **non-binding term sheet** to acquire **Mynaric AG**, a provider of laser optical communications terminals. A portion of the proceeds may be allocated to finance this acquisition. - The **ATM offering** allows Rocket Lab to sell shares at market prices over time, rather than issuing a fixed number of shares at a set price. - **Investing in Rocket Lab’s common stock carries risks**, including dilution, stock price volatility, and dependency on market conditions. ## Filing ![[61afe5ea-35cf-4e30-8272-4de7742e2197.pdf]]